Adipocytokine, omentin inhibits doxorubicin-induced H9c2 cardiomyoblasts apoptosis through the inhibition of mitochondrial reactive oxygen species

Biochemical and Biophysical Research Communications

Volumn 457, Issue 4, 2015, Pages 602-607

  Kazama, Kyosuke ^a   Okada, Muneyoshi ^a   Yamawaki, Hideyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Adipokine; Apoptosis; Cardiac toxicity; Doxorubicin; Mitochondrial reactive oxygen species

Indexed keywords

ADIPOCYTOKINE; APOPTOSIS INHIBITOR; CARDIOVASCULAR AGENT; CASPASE 3; CYTOPROTECTIVE AGENT; DOXORUBICIN; OMENTIN; REACTIVE OXYGEN METABOLITE; RECOMBINANT CYTOKINE; RED FLUORESCENT PROTEIN; ROTENONE; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; CARDIOTONIC AGENT; RECOMBINANT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL COUNT; CELL COUNTING; CELL PROTECTION; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; HEART MITOCHONDRION; HEART PROTECTION; MITOCHONDRIAL RESPIRATION; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STAINING; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CYTOLOGY; DRUG EFFECTS; METABOLISM; MITOCHONDRION; PATHOLOGY;

RATTUS;

ADIPOKINES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CARDIOTONIC AGENTS; CELL LINE; DOXORUBICIN; MITOCHONDRIA; MYOBLASTS, CARDIAC; RATS; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS;

EID: 84922696375     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.01.032     Document Type: Article

References (42)

1. H. Yamawaki Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses Biol. Pharm. Bull. 34 2011 307 310
2. A. Schaffler, M. Neumeier, H. Herfarth, A. Furst, J. Scholmerich, and C. Buchler Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue Biochim. Biophys. Acta 1732 2005 96 102
3. J.M. Moreno-Navarrete, V. Catalan, F. Ortega, J. Gomez-Ambrosi, W. Ricart, G. Fruhbeck, and J.M. Fernandez-Real Circulating omentin concentration increases after weight loss Nutr. Metab. (Lond) 7 2010 27
4. A. Saremi, M. Asghari, and A. Ghorbani Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men J. Sports Sci. 28 2010 993 998
5. H.J. Yoo, S.Y. Hwang, H.C. Hong, H.Y. Choi, S.J. Yang, J.A. Seo, S.G. Kim, N.H. Kim, K.M. Choi, D.S. Choi, and S.H. Baik Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes Cardiovasc Diabetol. 10 2011 103
6. R. Liu, X. Wang, and P. Bu Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome Diabetes Res. Clin. Pract. 93 2011 21 25
7. X.H. Wang, L.Z. Dou, C. Gu, and X.Q. Wang Plasma levels of omentin-1 and visfatin in senile patients with coronary heart disease and heart failure Asian Pac. J. Trop. Med. 7 2014 55 62
8. Q. Wang, X. Feng, C. Zhou, P. Li, and J. Kang Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome Ann. Clin. Biochem. 50 2013 230 235
9. M. Lapointe, P. Poirier, J. Martin, M. Bastien, A. Auclair, and K. Cianflone Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease Cardiovasc Diabetol. 13 2014 124
10. H. Yamawaki, J. Kuramoto, S. Kameshima, T. Usui, M. Okada, and Y. Hara Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells Biochem. Biophys. Res. Commun. 408 2011 339 343
11. K. Kazama, T. Usui, M. Okada, Y. Hara, and H. Yamawaki Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells Eur. J. Pharmacol. 686 2012 116 123
12. K. Kazama, M. Okada, and H. Yamawaki A novel adipocytokine, omentin, inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell migration through anti-oxidative mechanism Am. J. Physiol. Heart Circ. Physiol. 306 2014 H1714 H1719
13. H. Yamawaki, N. Tsubaki, M. Mukohda, M. Okada, and Y. Hara Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels Biochem. Biophys. Res. Commun. 393 2010 668 672
14. K. Matsuo, R. Shibata, K. Ohashi, T. Kambara, Y. Uemura, M. Hiramatsu-Ito, T. Enomoto, D. Yuasa, Y. Joki, M. Ito, S. Hayakawa, H. Ogawa, S. Kihara, T. Murohara, and N. Ouchi Omentin functions to attenuate cardiac hypertrophic response J. Mol. Cell. Cardiol. 79C 2014 195 202
15. Y. Kataoka, R. Shibata, K. Ohashi, T. Kambara, T. Enomoto, Y. Uemura, Y. Ogura, D. Yuasa, K. Matsuo, T. Nagata, T. Oba, H. Yasukawa, Y. Numaguchi, T. Sone, T. Murohara, and N. Ouchi Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms J. Am. Coll. Cardiol. 63 2014 2722 2733
16. S.E. Lipshultz, S.R. Lipsitz, S.M. Mone, A.M. Goorin, S.E. Sallan, S.P. Sanders, E.J. Orav, R.D. Gelber, and S.D. Colan Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer N. Engl. J. Med. 332 1995 1738 1743
17. Y. Octavia, C.G. Tocchetti, K.L. Gabrielson, S. Janssens, H.J. Crijns, and A.L. Moens Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies J. Mol. Cell. Cardiol. 52 2012 1213 1225
18. J. Finsterer, and P. Ohnsorge Influence of mitochondrion-toxic agents on the cardiovascular system Regul. Toxicol. Pharmacol. 67 2013 434 445
19. T. Silambarasan, J. Manivannan, M.K. Priya, N. Suganya, S. Chatterjee, and B. Raja Sinapic acid protects heart against ischemia/reperfusion injury and H9c2 cardiomyoblast cells against oxidative stress Biochem. Biophys. Res. Commun. 456 2015 853 859
20. T. Usui, T. Moriota, M. Okada, and H. Yamawaki Histone diacetylase 4 controls neointimal hyperplasia via stimulating proliferation and migration of vascular smooth muscle cells Hypertension 63 2014 397 403
21. T. Morita, M. Okada, Y. Hara, and H. Yamawaki Addition of adult serum improves endothelium-dependent relaxation of organ-cultured rat mesenteric artery via inhibiting mitochondrial reactive oxygen species Vasc. Pharmacol. 58 2013 105 111
22. D.R. Green, and J.C. Reed Mitochondria and apoptosis Science 281 1998 1309 1312
23. A.C. Moreira, A.F. Branco, S.F. Sampaio, T. Cunha-Oliveira, T.R. Martins, J. Holy, P.J. Oliveira, and V.A. Sardao Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts Biochim. Biophys. Acta 1842 2014 2468 2478
24. S.A. Lipton, and E. Bossy-Wetzel Dueling activities of AIF in cell death versus survival: DNA binding and redox activity Cell 111 2002 147 150
25. C. Sitticharoon, N.C. Nway, S. Chatree, M. Churintaraphan, P. Boonpuan, and P. Maikaew Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors Peptides 62C 2014 164 175
26. X. Zhong, H.Y. Zhang, H. Tan, Y. Zhou, F.L. Liu, F.Q. Chen, and D.Y. Shang Association of serum omentin-1 levels with coronary artery disease Acta Pharmacol. Sin. 32 2011 873 878
27. Y. Uemura, R. Shibata, N. Kanemura, K. Ohashi, T. Kambara, M. Hiramatsu-Ito, T. Enomoto, D. Yuasa, Y. Joki, K. Matsuo, M. Ito, S. Hayakawa, H. Ogawa, T. Murohara, and N. Ouchi Adipose-derived protein omentin prevents neointimal formation after arterial injury FASEB J. 29 2015 141 151
28. Y. Arita, S. Kihara, N. Ouchi, K. Maeda, H. Kuriyama, Y. Okamoto, M. Kumada, K. Hotta, M. Nishida, M. Takahashi, T. Nakamura, I. Shimomura, M. Muraguchi, Y. Ohmoto, T. Funahashi, and Y. Matsuzawa Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell Circulation 105 2002 2893 2898
29. M. Bluher, J.W. Bullen Jr., J.H. Lee, S. Kralisch, M. Fasshauer, N. Kloting, J. Niebauer, M.R. Schon, C.J. Williams, and C.S. Mantzoros Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training J. Clin. Endocrinol. Metab. 91 2006 2310 2316
30. G. Deng, Y. Long, Y.R. Yu, and M.R. Li Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS pathway Int. J. Obes. (Lond) 34 2010 165 171
31. Y. Motobayashi, Y. Izawa-Ishizawa, K. Ishizawa, S. Orino, K. Yamaguchi, K. Kawazoe, S. Hamano, K. Tsuchiya, S. Tomita, and T. Tamaki Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells Hypertens. Res. 32 2009 188 193
32. B.K. Son, M. Akishita, K. Iijima, K. Kozaki, K. Maemura, M. Eto, and Y. Ouchi Adiponectin antagonizes stimulatory effect of tumor necrosis factor-α on vascular smooth muscle cell calcification: regulation of growth arrest-specific gene 6-mediated survival pathway by adenosine 5′-monophosphate-activated protein kinase Endocrinology 149 2008 1646 1653
33. T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, and T. Kadowaki Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762 769
34. I.P. Chou, Y.P. Chiu, S.T. Ding, B.H. Liu, Y.Y. Lin, and C.Y. Chen Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice-possible involvement of oxidative stress and autophagy Endocr. Res. 39 2014 173 179
35. 2-induced mitochondrial dysfunction and apoptosis Int. J. Med. Sci. 11 2014 1107 1115
36. P.K. Sobhan, M. Seervi, L. Deb, S. Varghese, A. Soman, J. Joseph, K.A. Mathew, G. Raghu, G. Thomas, S. E, M. S, and S.K. R Calpain and reactive oxygen species targets Bax for mitochondrial permeabilisation and caspase activation in zerumbone induced apoptosis PLoS One 8 2013 e59350
37. Y. Liu, Z. Huo, B. Yan, X. Lin, Z.N. Zhou, X. Liang, W. Zhu, D. Liang, L. Li, Y. Liu, H. Zhao, Y. Sun, and Y.H. Chen Prolyl hydroxylase 3 interacts with Bcl-2 to regulate doxorubicin-induced apoptosis in H9c2 cells Biochem. Biophys. Res. Commun. 401 2010 231 237
38. L. Hosseinzadeh, J. Behravan, F. Mosaffa, G. Bahrami, A. Bahrami, and G. Karimi Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species Food Chem. Toxicol. 49 2011 1102 1109
39. K.M. Tewey, T.C. Rowe, L. Yang, B.D. Halligan, and L.F. Liu Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II Science 226 1984 466 468
40. P.K. Singal, and N. Iliskovic Doxorubicin-induced cardiomyopathy N. Engl. J. Med. 339 1998 900 905
41. I. Muller, D. Niethammer, and G. Bruchelt Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (review) Int. J. Mol. Med. 1 1998 491 494
42. Y. Octavia, H.P. Brunner-La Rocca, and A.L. Moens NADPH oxidase-dependent oxidative stress in the failing heart: from pathogenic roles to therapeutic approach Free Radic. Biol. Med. 52 2012 291 297